131 related articles for article (PubMed ID: 38513191)
1. Comparison of Clinicopathological Features of Pleomorphic and Invasive Lobular Breast Carcinomas.
Sağdıç MF; Güler OC; Subaşı O; Albayrak Ö; Özaslan C
Am Surg; 2024 Jun; 90(6):1383-1389. PubMed ID: 38513191
[TBL] [Abstract][Full Text] [Related]
2. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.
Ilic IR; Djordjevic NP; Randjelovic PJ; Stojanovic NM; Radulovic NS; Ilic RS
J BUON; 2016; 21(5):1113-1120. PubMed ID: 27837612
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
van Deurzen CH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
[TBL] [Abstract][Full Text] [Related]
5. The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma.
Tasli F; Cavdar D; Kececi SD; Zengel B; Adibelli ZH; Dal G; Gonen I; Oz O; Yilmaz C; Ozdemir O; Mollamehmetoglu H; Dilek I; Ilhan E; Uslu A
Breast J; 2022; 2022():2461242. PubMed ID: 36237576
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?
Rakha EA; van Deurzen CH; Paish EC; Macmillan RD; Ellis IO; Lee AH
Mod Pathol; 2013 Apr; 26(4):496-501. PubMed ID: 23238630
[TBL] [Abstract][Full Text] [Related]
7. Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis.
Liu YL; Choi C; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
Clin Breast Cancer; 2018 Apr; 18(2):114-120. PubMed ID: 28720418
[TBL] [Abstract][Full Text] [Related]
8. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
9. Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?
Soucy G; Bélanger J; Leblanc G; Sideris L; Drolet P; Mitchell A; Leclerc YE; Dufresne MP; Beaudet J; Dubé P
J Am Coll Surg; 2008 Jun; 206(6):1116-21. PubMed ID: 18501808
[TBL] [Abstract][Full Text] [Related]
10. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.
Mukhtar RA; Wong J; Piper M; Zhu Z; Fahrner-Scott K; Mamounas M; Sbitany H; Alvarado M; Foster R; Ewing C; Esserman L
Ann Surg Oncol; 2018 Oct; 25(11):3165-3170. PubMed ID: 30054826
[TBL] [Abstract][Full Text] [Related]
11. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.
Haque W; Arms A; Verma V; Hatch S; Brian Butler E; Teh BS
Breast; 2019 Feb; 43():67-73. PubMed ID: 30496936
[TBL] [Abstract][Full Text] [Related]
14. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
[TBL] [Abstract][Full Text] [Related]
15. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
Frolik D; Caduff R; Varga Z
Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
[TBL] [Abstract][Full Text] [Related]
17. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.
Dillon MF; Hill AD; Fleming FJ; O'Doherty A; Quinn CM; McDermott EW; O'Higgins N
Am J Surg; 2006 Feb; 191(2):201-5. PubMed ID: 16442946
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic lobular carcinoma in a male breast: a case report with review of the literature.
Ishida M; Mori T; Umeda T; Kawai Y; Kubota Y; Abe H; Iwai M; Yoshida K; Kagotani A; Tani T; Okabe H
Int J Clin Exp Pathol; 2013; 6(7):1441-4. PubMed ID: 23826429
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ and invasive lobular cancer of the breast.
Cocquyt V; Van Belle S
Curr Opin Obstet Gynecol; 2005 Feb; 17(1):55-60. PubMed ID: 15711412
[TBL] [Abstract][Full Text] [Related]
20. Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.
Al-Baimani K; Bazzarelli A; Clemons M; Robertson SJ; Addison C; Arnaout A
Clin Breast Cancer; 2015 Dec; 15(6):421-5. PubMed ID: 26209026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
